Achillion Pharmaceuticals (ACHN)
Create an Alert
8.13
+0.12 +1.50%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Achillion Pharmaceuticals Return on Equity:
-53.34% for March 31, 2013Achillion Pharmaceuticals Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -53.34% |
| Dec. 31, 2012 | -68.89% |
| Sept. 30, 2012 | -68.58% |
| June 30, 2012 | -59.99% |
| March 31, 2012 | -61.70% |
| Dec. 31, 2011 | -65.62% |
| Sept. 30, 2011 | -59.17% |
| June 30, 2011 | -69.11% |
| March 31, 2011 | -83.94% |
| Dec. 31, 2010 | -91.99% |
| Sept. 30, 2010 | -136.4% |
| June 30, 2010 | -239.6% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
ACHN Return on Equity Benchmarks
| Companies | |
|---|---|
| Transcept Pharmaceuticals | -19.72% |
| Merrimack Pharmaceuticals | |
| Vertex Pharmaceuticals | -53.43% |
ACHN Return on Equity Rankings
| Overall |
62nd percentile 6284 of 16782 |
| Sector |
67th percentile 462 of 1410 in Healthcare |
| Industry |
78th percentile 97 of 454 in Biotechnology |
ACHN Return on Equity Range, Past 5 Years
| Minimum | -239.6% | Jun 2010 |
| Maximum | -53.34% | Mar 2013 |
| Average | -113.2% |
